Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy
Hale Başak Çağlar(Brigham and Women's Hospital), Aaron M. Allen(Tel Aviv University), Lori J. Wirth(Massachusetts General Hospital), Megan Othus(Cancer Research And Biostatistics), Laura A. Goguen(Brigham and Women's Hospital), Laurence E. Court(The University of Texas MD Anderson Cancer Center), Li Yi(Harvard University), Carl M. Norris(Harvard University Press), Roy B. Tishler(Dana-Farber Cancer Institute), Robert I. Haddad(Georgetown University), Donald J. Aninno(Harvard University Press), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Elaine Burke(St Thomas' Hospital)
Cited by 230
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926